Flomoxef is an oxacephem antibiotic that was developed by Shionogi.
Clinical data | |
---|---|
Trade names | Flumarin |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H18F2N6O7S2 |
Molar mass | 496.46 g·mol−1 |
3D model (JSmol) | |
Melting point | 82.5 to 87.5 °C (180.5 to 189.5 °F) |
| |
| |
(what is this?) (verify) |
It has been classified either as a second-generation [1] or fourth-generation cephalosporin.[2]
It was patented in 1982 and approved for medical use in 1988 under the trade name Flumarin.[3]
References
edit- ^ Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S (April 2008). "Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration". General Thoracic and Cardiovascular Surgery. 56 (4): 163–169. doi:10.1007/s11748-007-0208-5. PMID 18401677. S2CID 23845740.163-169&rft.date=2008-04&rft_id=https://api.semanticscholar.org/CorpusID:23845740#id-name=S2CID&rft_id=info:pmid/18401677&rft_id=info:doi/10.1007/s11748-007-0208-5&rft.aulast=Masuda&rft.aufirst=Z&rft.au=Kurosaki, Y&rft.au=Ishino, K&rft.au=Yamauchi, K&rft.au=Sano, S&rfr_id=info:sid/en.wikipedia.org:Flomoxef" class="Z3988">
- ^ Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 (Suppl 5): S253 – S257. doi:10.1007/bf01645536. PMID 1783441. S2CID 25339977.S253 - S257&rft.date=1991&rft_id=https://api.semanticscholar.org/CorpusID:25339977#id-name=S2CID&rft_id=info:pmid/1783441&rft_id=info:doi/10.1007/bf01645536&rft.aulast=Ito&rft.aufirst=M&rft.au=Ishigami, T&rfr_id=info:sid/en.wikipedia.org:Flomoxef" class="Z3988">
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 496. ISBN 9783527607495.